824 INDEX
azathioprine, 752
adverse effects, 197, 625
for anal furunculosis/perianal fistula, 164
for canine eosinophilic granuloma, 355
for cutaneous adverse drug reactions, 275
for epidermolysis bullosa acquisita, 197
for lupus erythematosus, 472
for panniculitis, 566
for pemphigus complex, 196, 624
for reactive systemic histiocytosis, 387
for uveodermatologic syndrome, 693, 694
for vasculitis, 702
azithromycin,218,715, 752
Aziumseedexamethasone
AZTseezidovudine
Azulfidineseesulfasalazine
baby oil, 650
bacteria
culture and identification, 28, 30–31,34–35
cytology, 45
resident skin, 211–212
transient skin, 212
bacterial dysbiosis, 211
bacterial infections
acne, 158
anal sac, 169, 170, 172
antibiotic resistance, 142–148
categories, 213
claw and clawfold, 66,132, 590
client education, 146–147
nodules and draining sinuses, 67–68
otitis externa/media, 545, 547, 548
surface, 213
systemic therapy, 151–152
topical therapy, 142, 151
zoonotic potential, 146, 728
see alsofolliculitis, bacterial; furunculosis;
pyoderma, bacterial
bacterial overgrowth syndrome, 215, 225
Bactrimseetrimethoprim + sulfamethoxazole
ballooning degeneration, 39
Banamineseeflunixin meglumine
basal cell carcinoma, 676
basal cell tumors, 673
clinical features, 676, 685
diagnostics, 677, 678
differential diagnosis, 677
prognosis, 679
signalment/history, 673, 674, 675
therapeutics, 678–679
basenji, 732
basset hound, 732
congenital alopecia, 61
Malasseziadermatitis, 481, 489
mast cell tumors, 495
mycobacterial infections, 511
nasodigital hyperkeratosis, 433–434
primary seborrhea, 433,443, 444
solar-induced dermatoses, 575, 616, 673
trichoepithelioma, 674
uveodermatologic syndrome, 692
Baytrilseeenrofloxacin
beagle, 732
amyloidosis, 617
congenital alopecia, 61
hyperadrenocorticism, 395
hypothyroidism, 417
juvenile polyarteritis syndrome, 63, 699
mast cell tumors, 495
nasodigital hyperkeratosis, 433–434
photodermatoses, 575, 673
sebaceous adenitis, 648, 657
skin tumors, 673
bearded collie, 732
Beauceron shepherd dog, 312, 732
Bedlington terrier, 732
bee stings, 240–241, 243, 264
behavioral dermatoses, 227–234
clinical features, 228–230,235–238
comments, 234
diagnostics, 231–232
differential diagnosis, 230–231
etiology/pathophysiology, 227–228
secondary, 227
signalment/history, 228
therapeutics, 233–234
behavior modification therapy, 233, 234
Belgian sheepdog, 732
Belgian shepherd dog, 65
Belgian tervuren, 732
Benadrylseediphenhydramine
benzoyl peroxide, 151, 159, 437
Bernese mountain dog, 381, 732
betamethasone, 196, 197, 472, 753
Biaxinseeclarithromycin
bichon frise, 61, 732
biofilms, 144, 151
biological therapy, for atopic disease, 181
biopsy, 36–41
atopic disease, 178–179
contact dermatitis, 267
dermatomyositis, 314
dermatophytosis, 323, 336
indications, 36
panniculitis, 565–566,572–573
pathology report, 38,38–41, 41
samples for bacterial culture, 30–31
site selection, 36–37
technique, 37–38,41–42
touch imprints, 46,54–55
vasculitis, 701
see alsohistopathology
Biosolseeneomycin
birman cat, 61
black flies (Simuliumspp.), 240